Back to search

France· FR:66227027

DYSALFA 5 mg, comprimé

A medicinal product containing chlorhydrate de térazosine dihydraté, registered in France by AMDIPHARM, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedDYSALFA 5 mg, compriméATC—REGISTER NO.FR:66227027PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE DE TÉRAZOSINE DIHYDRATÉ
Manufacturer
AMDIPHARM
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400934243158
    plaquette(s) thermoformée(s) PVC PVDC aluminium de 28 comprimé(s)
    EUR 12.06

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Chlorhydrate de térazosine dihydraté in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chlorhydrate de térazosine dihydraté products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Uroflo, Vicard
  • Belgium · Hytrin, Terazosab
  • Czechia · Kornam
  • Germany · Heitrin, Tera Tad
  • Denmark · Sinalfa
  • Spain · Alfaprost, Mayul
  • United Kingdom (Northern Ireland) · Hytrin, Terazosin
  • Greece · Hytrin
  • Hungary · Setegis
  • Ireland · Hytrin
  • Italy · Itrin, Prostatil
  • Luxembourg · Hytrin, Terazosab
  • Netherlands · Hytrin, Terazosine Accord
  • Norway · Sinalfa
  • Poland · Hytrin, Kornam
  • Portugal · Hytrin
  • Sweden · Sinalfa
  • Slovenia · Kornam
  • Slovakia · Kornam

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/784457a5-c4b6-42b4-aaa5-6e005e56ae07
GET /v1/drugs/784457a5-c4b6-42b4-aaa5-6e005e56ae07?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66227027",
  "date_amm": "1997-01-07",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "CHLORHYDRATE DE TÉRAZOSINE DIHYDRATÉ",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about chlorhydrate de térazosine dihydraté.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.